Cargando…

Limitations of insulin resistance assessment in polycystic ovary syndrome

BACKGROUND: Though insulin resistance (IR) is common in polycystic ovary syndrome (PCOS), there is no agreement as to what surrogate method of assessment of IR is most reliable. SUBJECTS AND METHODS: In 478 women with PCOS, we compared methods based on fasting insulin and either fasting glucose (HOM...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lewandowski, Krzysztof C, Płusajska, Justyna, Horzelski, Wojciech, Bieniek, Ewa, Lewiński, Andrzej
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834769/ https://www.ncbi.nlm.nih.gov/pubmed/29436386 http://dx.doi.org/10.1530/EC-18-0021

Ejemplares similares

How much insulin resistance in polycystic ovary syndrome? Comparison of HOMA-IR and insulin resistance (Belfiore) index models
por: Lewandowski, Krzysztof C., et al.
Publicado: (2019)

Limited Role of Endogenous Vasopressin/Copeptin in Stimulation of ACTH–Cortisol Secretion during Glucagon Stimulation Test in Humans
por: Malicka, Katarzyna, et al.
Publicado: (2022)

Frequency of COVID-19 Infection as a Function of Vitamin D Levels
por: Basińska-Lewandowska, Magdalena, et al.
Publicado: (2023)

Renin, Aldosterone, and Cortisol in Pregnancy-Induced Hypertension
por: Lewandowski, Krzysztof C, et al.
Publicado: (2023)

Insulin resistance and fertility in polycystic ovary syndrome.
por: Fica, S, et al.
Publicado: (2008)

Metformin paradoxically worsens insulin resistance in SHORT syndrome
por: Lewandowski, Krzysztof C., et al.
Publicado: (2019)

Copeptin under glucagon stimulation
por: Lewandowski, Krzysztof C., et al.
Publicado: (2015)

Copeptin as a marker of an altered CRH axis in pituitary disease
por: Lewandowski, Krzysztof C., et al.
Publicado: (2017)

New markers of insulin resistance in polycystic ovary syndrome
por: Polak, K., et al.
Publicado: (2016)

Is Insulin Resistance an Intrinsic Defect in Asian Polycystic Ovary Syndrome?
por: Lee, Hyejin, et al.
Publicado: (2013)

Markers of insulin resistance in Polycystic ovary syndrome women: An update
por: Amisi, Chantal Anifa
Publicado: (2022)

Association between polycystic ovarian morphology and insulin resistance in women with polycystic ovary syndrome
por: Lee, Jeong Eun, et al.
Publicado: (2023)

Effects of insulin-sensitizing agents and insulin resistance in women with polycystic ovary syndrome
por: Hwang, Kyu Ri, et al.
Publicado: (2013)

Body Composition, Serum Concentrations of Androgens and Insulin Resistance in Different Polycystic Ovary Syndrome Phenotypes
por: Polak, Aleksandra Maria, et al.
Publicado: (2020)

Retinol-Binding Protein 4 and Insulin Resistance in Polycystic Ovary Syndrome
por: Hutchison, Samantha K., et al.
Publicado: (2008)

Subclinical hypothyroidism and insulin resistance in polycystic ovary syndrome: is there a relationship?
por: Enzevaei, Anahita, et al.
Publicado: (2014)

Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth
por: Rojas, Joselyn, et al.
Publicado: (2014)

The relation of dermcidin with insulin resistance and inflammation in women with polycystic ovary syndrome
por: Akan, Ozden Yildirim, et al.
Publicado: (2022)

Polycystic Ovary Syndrome as Metabolic Disease: New Insights on Insulin Resistance
por: Genazzani, Alessandro D, et al.
Publicado: (2023)

Identification of Differentially Expressed MicroRNAs in the Ovary of Polycystic Ovary Syndrome with Hyperandrogenism and Insulin Resistance
por: Lin, Lin, et al.
Publicado: (2015)

Abdominal Obesity in Women with Polycystic Ovary Syndrome and Its Relationship with Diet, Physical Activity and Insulin Resistance: A Pilot Study
por: Jurczewska, Justyna, et al.
Publicado: (2023)

World Congress on the Insulin Resistance Syndrome, 2009: Insulin resistance mechanisms, the brain, and insulin resistance in youth and in the polycystic ovary syndrome
por: Bloomgarden, Zachary T.
Publicado: (2010)

Afamin serum concentrations are associated with insulin resistance and metabolic syndrome in polycystic ovary syndrome
por: Seeber, Beata, et al.
Publicado: (2014)

Myo-inositol for insulin resistance, metabolic syndrome, polycystic ovary syndrome and gestational diabetes
por: DiNicolantonio, James J, et al.
Publicado: (2022)

Diamel Therapy in Polycystic Ovary Syndrome Reduces Hyperinsulinaemia, Insulin Resistance, and Hyperandrogenaemia
por: Hernández-Yero, Arturo, et al.
Publicado: (2012)

Relationship between Serum Lipoprotein Ratios and Insulin Resistance in Polycystic Ovary Syndrome
por: Xiang, Shou-Kui, et al.
Publicado: (2012)

Recurrent Pregnancy Loss in Polycystic Ovary Syndrome: Role of Hyperhomocysteinemia and Insulin Resistance
por: Chakraborty, Pratip, et al.
Publicado: (2013)

Insulin Resistance and Serum Magnesium Concentrations among Women with Polycystic Ovary Syndrome
por: Hamilton, Kristen P, et al.
Publicado: (2019)

Associations of Serum Magnesium With Insulin Resistance and Testosterone in Women With Polycystic Ovary Syndrome
por: Luo, Xi, et al.
Publicado: (2021)

Does insulin resistance increase thyroid volume in patients with polycystic ovary syndrome?
por: Sahin, Murat, et al.
Publicado: (2016)

Effects of Moringa oleifera on Insulin Levels and Folliculogenesis in Polycystic Ovary Syndrome Model with Insulin Resistance
por: Amelia, Dessy, et al.
Publicado: (2018)

The Role of Glp-1 Receptor Agonists in Insulin Resistance with Concomitant Obesity Treatment in Polycystic Ovary Syndrome
por: Bednarz, Krzysztof, et al.
Publicado: (2022)

Type A insulin resistance syndrome misdiagnosed as polycystic ovary syndrome: a case report
por: Lin, Lu, et al.
Publicado: (2019)

Association between Insulin Resistance and Cardiovascular Risk Factors in Polycystic Ovary Syndrome Patients
por: Wanderley, Miriam da Silva, et al.
Publicado: (2018)

Obesity and Insulin Resistance Are the Main Determinants of Postprandial Lipoprotein Dysmetabolism in Polycystic Ovary Syndrome
por: Kyaw Tun, Tommy, et al.
Publicado: (2016)

Circulating Zinc-α2-glycoprotein levels and Insulin Resistance in Polycystic Ovary Syndrome
por: Lai, Yerui, et al.
Publicado: (2016)

Optimal Cutoff Points for Anthropometric Variables to Predict Insulin Resistance in Polycystic Ovary Syndrome
por: Hatami, Hossein, et al.
Publicado: (2017)

Insulin resistance and obesity among infertile women with different polycystic ovary syndrome phenotypes
por: Al-Jefout, Moamar, et al.
Publicado: (2017)

Serum betatrophin levels are increased and associated with insulin resistance in patients with polycystic ovary syndrome
por: Qu, Qinglan, et al.
Publicado: (2017)

MON-223 Adipose Insulin Resistance in Normal-Weight Women with Polycystic Ovary Syndrome
por: Hoyos, Luis, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_upu8omtmqfrkue5pfb9vbmc5vq